NCT00002411已完成不适用
A Randomized Study of the Long-Term Suppression of Plasma HIV RNA Levels by Triple Combination Regimens in Treatment Naive Subjects
Bristol-Myers Squibb63 个研究点 分布在 1 个国家开始时间: 1998年3月最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 试验地点
- 63
研究概览
简要总结
The purpose of this study is to compare the safety of didanosine plus stavudine plus nelfinavir (NLF) with that of zidovudine plus lamivudine plus NLF. This study also examines how long these drug combinations are effective in lowering viral load (level of HIV in the blood).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 12 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (63)
Loading locations...
相似试验
已完成
不适用
A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected PatientsHIV InfectionsNCT00002207Bristol-Myers Squibb
已完成
3 期
Rollover Study for Zerit (Stavudine) ER Studies (-096, -099)AIDSHIV InfectionsNCT00116298Bristol-Myers Squibb900
Unknown
2 期
Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice DailyHIV InfectionsNCT00002241Merck Sharp & Dohme LLC80
已完成
3 期
Dose Optimisation of Stavudine for the Treatment of HIV InfectionAcquired Immune Deficiency SyndromeHuman Immunodeficiency VirusNCT02670772Willem Daniel Francois Venter1,077
已完成
2 期
A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take ZidovudineHIV InfectionsNCT00000963National Institute of Allergy and Infectious Diseases (NIAID)300